| Sebbane, Mustapha |
| Recruiting | 3 | 650 | Europe, Canada, RoW | Alteplase, Placebo | Assistance Publique - Hôpitaux de Paris, Johannes Gutenberg University Mainz, Life Sciences Research Partners (D Collen Research Foundation), Canadian Institutes of Health Research (CIHR), Instituto de Salud Carlos III, International Network of VENous Thromboembolism Clinical Research Networks, Boehringer Ingelheim | Pulmonary Embolism | 09/25 | 08/27 | | |
HiCOPD, NCT06114667: Nasal High Flow Versus Non-invasive Ventilation for Early Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease With Hypercapnic Acidosis |
|
|
| Not yet recruiting | N/A | 174 | Europe | Ventilatory support via nasal high flow, Ventilatory support via NIV | University Hospital, Montpellier, Fisher and Paykel Healthcare | Acute Exacerbation of Chronic Obstructive Pulmonary Disease, Hypercapnic Acidosis, Respiratory Failure With Hypercapnia | 05/26 | 06/26 | | |
| RENARD, Eric |
| Recruiting | N/A | 72 | Europe | Closed-loop insulin infusion driven by continuous glucose monitoring through an algorithm, in free-life conditions, Artificial Pancreas, Continuous Subcutaneous Insulin Infusion and Continuous Glucose Monitoring, Sensor Augmented Pump, CSII and CGM | University Hospital, Montpellier, Tandem Diabetes Care, Inc., DexCom, Inc., National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), University of Virginia | Type 1 Diabetes Mellitus With Hypoglycemia | 11/22 | 02/23 | | |
| Active, not recruiting | N/A | 200 | Europe, US | Omnipod 5 System | Insulet Corporation | Type 1 Diabetes | 09/23 | 01/25 | | |
| Active, not recruiting | N/A | 200 | Europe | Omnipod 5 System | Insulet Corporation | Diabetes Mellitus, Type 1 | 08/24 | 08/25 | | |
| Quere, Isabelle |
| Completed | 3 | 1766 | Europe, Canada | Apixaban 5 MG, Apixaban 2.5 MG | Assistance Publique - Hôpitaux de Paris, Bristol-Myers Squibb | Cancer-associated Thrombosis | 09/24 | 10/24 | | |
NCT03492476: Circaid® Compression Sleeve Versus Short-stretching Bandage in Upper Limb Lymphatic Edema |
|
|
| Completed | N/A | 142 | Europe | Circaid, Non-elastic bands, Short-stretching Bandage (Reference treatment) | CEN Biotech, medi | Lymphedema of Upper Arm | 03/22 | 03/22 | | |
LYMphoNIGHT, NCT04203069: Auto-Adjustable MOBIDERM® Autofit NIGHT-time Compression Armsleeve in the Upper Limb LYMphedema in Maintenance Phase |
|
|
| Completed | N/A | 63 | Europe, RoW | Control group : Day-time compression sleeve, Intervention group : Day-time compression sleeve and Night-time MOBIDERM® Autofit | Thuasne, International Clinical Trials Association | Lymphedema of Upper Arm | 12/23 | 09/24 | | |
| COZE, Carole |
NCT04253015: A Post-Authorisation Safety Study Patient Registry of Patients With Neuroblastoma Being Treated With Dinutuximab Beta |
|
|
| Recruiting | N/A | 125 | Europe | Data-collection | EusaPharma (UK) Limited, United BioSource, LLC | Neuroblastoma | 03/32 | 06/32 | | |
| GENY, Christian |
LUMA, NCT05348785 / 2021-004849-20: A Study to Learn About the Safety of BIIB122 Tablets and Whether They Can Slow the Worsening of Early-Stage Parkinson's Disease in Adults Between the Ages of 30 and 80 |
|
|
| Recruiting | 2 | 640 | Europe, Canada, Japan, US, RoW | BIIB122, DNL151, BIIB122-Matching Placebo | Biogen, Denali Therapeutics Inc. | Parkinson Disease | 12/25 | 12/25 | | |
| Dereure, Olivier |
| Active, not recruiting | 2 | 170 | Europe, US | IPH4102, lacutamab | Innate Pharma | Lymphoma, T-Cell, Lymphoma, T-Cell, Cutaneous, Mycosis Fungoides/Sezary Syndrome | 10/23 | 01/26 | | |
|
|
|
|
|
|
| Active, not recruiting | 2 | 10 | Europe | Stereotaxic radiosurgery (SRS), Binimetinib Oral Tablet, Mektovi, Encorafenib Oral Capsule, Braftovi, Pembrolizumab, Keytruda | UNICANCER, European Association of Dermato Oncology, Pierre Fabre Medicament, Merck Sharp & Dohme LLC | Malignant Melanoma, BRAF V600 Mutation, Brain Metastases | 04/25 | 04/29 | | |
| DAUVILLIERS, Yves |
DARIDOR-ALZ, NCT05924425: Daridorexant to Treat Insomnia in Patients With Mild Cognitive Impairment and Mild to Moderate Alzheimer Disease |
|
|
| Recruiting | 4 | 62 | Europe | Daridorexant 50 mg, Placebo, Polysomnography, Neuropsychological assessment, Questionnaires on sleep and behavioural problems, Actimetrics, 24-hour Ambulatory Blood Pressure Monitoring (ABPM, Biomarker assay | University Hospital, Montpellier, Idorsia Pharmaceuticals Ltd. | Alzheimer Disease, Insomnia Disorder, Sleep | 05/26 | 03/27 | | |
SUNSAS, NCT05057975: Validation of an Integrated Digital Solution (SUNrise®) Versus Polysomnography for Obstructive Sleep Apnea Diagnosis |
|
|
| Completed | N/A | 848 | Europe | Sunrise, polysomnography | Sunrise, ICUREsearch | Obstructive Sleep Apnea | 10/24 | 10/24 | | |
| Daien, Claire I |
| Terminated | N/A | 27 | Europe | Blood sample analysis of patients treated as standard care | University Hospital, Montpellier, Centre National de la Recherche Scientifique, France, Pfizer | Rheumatoid Arthritis | 08/22 | 11/22 | | |
| Costalat, Vincent |
| Recruiting | N/A | 170 | Europe, RoW | Endovascular treatment of unruptured aneurysms with p64 MW HPC Flow Modulation Device | Phenox GmbH | Intracranial Aneurysm | 12/24 | 12/24 | | |
NCT05139147: DAISe 1 Feasibility Study to Evaluate the DAISe Thrombectomy System for Acute Ischemic Stroke |
|
|
| Terminated | N/A | 16 | Europe | DAISe Thrombectomy System | MIVI Neuroscience, Inc. | Acute Ischemic Stroke | 07/23 | 08/23 | | |
IMPACT, NCT04572230: International Post Market Surveillance Study of Intracranial Aneurysms Treated With an Endovascular Approach |
|
|
| Active, not recruiting | N/A | 405 | Europe | Endovascular treatment of intracranial aneurysms using a flow-diverting stent | Stryker Neurovascular | Intracranial Aneurysm | 09/24 | 09/25 | | |
| Recruiting | N/A | 119 | Europe | Implantation of an eCLIPs™ device, eCLIPs™ Electrolytic Bifurcation Systems | Evasc Medical Systems Corp., European Cardiovascular Research Center | Intracranial Aneurysm | 04/25 | 04/26 | | |
| Recruiting | N/A | 279 | US | The SEAL™ Saccular Endovascular Aneurysm Lattice System | Galaxy Therapeutics INC | Intracranial Aneurysm | 09/26 | 09/30 | | |
| Active, not recruiting | N/A | 150 | Europe | | Stryker Neurovascular | Aneurysm, Intracranial Aneurysm | 09/26 | 03/27 | | |
| WOJTUSCISZYN, Anne |
SigiFIH, NCT05973422: Sigi Insulin Management System - A First-in-Human Study in Adults With Type 1 Diabetes |
|
|
| Not yet recruiting | N/A | 10 | NA | SIGI Insulin Management System | Tandem Diabetes Care, Inc. | Type 1 Diabetes | 09/24 | 09/24 | | |
| Demoly, Pascal |
| Completed | N/A | 1635 | Europe | | Stallergenes Greer | Allergic Rhinitis | 07/20 | 10/21 | | |
SPRA, NCT05443945: Efficacy of ADW S-100 Ionized Water Nasal Spray in Decreasing Symptoms of Allergic Rhinitis |
|
|
| Completed | N/A | 95 | Europe | Nasal Spray | P & B Group, MediAxe CRO | Allergic Rhinitis | 08/23 | 08/23 | | |
| LECLERCQ, FLORENCE |
AVATAR, NCT02735902: Anticoagulation Alone Versus Anticoagulation and Aspirin Following Transcatheter Aortic Valve Interventions (1:1) |
|
|
| Completed | 4 | 170 | Europe | Vitamin K antagonist or direct oral anticoagulant treatment, Aspirin | Centre Hospitalier Universitaire de Nīmes, Medtronic | Transcatheter Aortic Valve Replacement | 02/23 | 01/24 | | |
AQUATIC, NCT04217447: Assessment of Quitting Versus Using Aspirin Therapy in Patients Treated with Oral Anticoagulation for Atrial Fibrillation or Other Indication with Stabilized Coronary Artery Disease |
|
|
| Terminated | 3 | 874 | Europe | OAC + Aspirin 100mg od, OAC + placebo of Aspirin 100mg od | University Hospital, Brest, Bayer | Coronary Artery Disease | 10/24 | 10/24 | | |
BENCHMARK, NCT04579445: Setting a Benchmark for Resource Utilization and Quality of Care in Patients Undergoing TAVI in Europe |
|
|
| Completed | N/A | 2408 | Europe, RoW | Education on tailored Quality Improvement measures, Education on Quality of Care Improvement measures | Institut für Pharmakologie und Präventive Medizin, Edwards Lifesciences | Transcatheter Aortic Valve Implantation (TAVI) | 04/23 | 08/24 | | |
| Recruiting | N/A | 90 | Europe | Pacemaker and defibrillator | University Hospital, Montpellier, Biotronik France | Patients Above 18 Years, Patient Discharge, Pacing Therapy, Aortic Stenosis (Treated With TAVI) | 10/25 | 10/27 | | |
| PERS, Yves-Marie |
| Active, not recruiting | 3 | 154 | Europe, Canada, US, RoW | Veligrotug (VRDN-001) Phase 1/2 MAD (HV and TED), VRDN-001 Phase 3 Cohort (THRIVE), VRDN-001 Placebo | Viridian Therapeutics, Inc., Viridian Therapeutics, Inc. | Thyroid Eye Disease | 07/24 | 03/25 | | |
NCT05727371: Combination of PRP and XLHA Prepared With RegenMatrix Medical Device To Treat Moderate to Severe Knee Osteoarthritis |
|
|
| Recruiting | N/A | 280 | Europe | Regen Matrix-PRP-XLHA, Hylan G-F 20, Placebo | RegenLab France SAS | Knee Osteoarthritis | 02/25 | 08/25 | | |
| Haouy, Stéphanie |
| Recruiting | 3 | 6430 | Europe, RoW | Omitted Doxorubicin, Omitted Vincristine+Dexamethasone pulses, Inotuzumab Ozogamicin+Standard Maintenance Therapy, Besponsa+Maintenance Therapy, Imatinib, 6-tioguanine+Standard Maintenance Therapy, Blinatumomab, Blincyto | Mats Heyman, The Swedish Research Council, The Swedish Childhood Cancer Foundation, Pfizer, Servier, NordForsk, Aamu Pediatric Cancer Foundation, German Society for Pediatric Oncology and Hematology GPOH gGmbH, Clinical Trial Center North (CTC North GmbH & Co. KG), Belgium Health Care Knowledge Centre, Karolinska Institutet, Cancer Research UK, Fundação Rui Osório de Castro, Acreditar - Associação de Pais e Amigos das Crianças com Cancro, Grupo Português De Leucemias Pediátricas, Amgen, Nova Laboratories Limited, Danish Child Cancer Foundation, Danish Cancer Society, The Novo Nordic Foundation, Assistance Publique - Hôpitaux de Paris, Direction Générale de l'Offre de Soins | Leukemia, Acute Lymphoblastic | 06/27 | 06/32 | | |
| FAURE, Stéphanie |
| Not yet recruiting | 4 | 93 | Europe | dulaglutide (TRULICITY®) 1.5 mg, reinforced dietary monitoring | Central Hospital, Nancy, France, Eli Lilly and Company | Diabetes Mellitus, Type 2, NASH - Nonalcoholic Steatohepatitis | 09/23 | 03/24 | | |
NATiV3, NCT04849728: A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( ) |
|
|
| Recruiting | 3 | 1000 | Europe, Canada, US, RoW | IVA337, Lanifibranor, Placebo | Inventiva Pharma | NASH - Nonalcoholic Steatohepatitis | 09/25 | 09/26 | | |
| Soltani, Sonia |
EVERGREEN, NCT05479305: Evaluation of the Valiant Captivia Physician Fenestrated Stent Graft System in Aortic Arch and Descending Thoracic Aorta Pathologies |
|
|
| Recruiting | N/A | 30 | Europe | The Valiant Captivia Stent Graft | Ceric Sàrl, European Cardiovascular Research Center | Penetrating Ulcer of Aorta, Aneurysm Aortic, Type B Aortic Dissection, Residual Dissection After Type A Repair | 11/24 | 10/27 | | |
| Marelli, Cecilia |
| Recruiting | 1/2 | 65 | Europe, RoW | VO659 | Vico Therapeutics B. V., VICO Therapeutics B.V. | Spinocerebellar Ataxia Type 1, Spinocerebellar Ataxia Type 3, Huntington Disease | 09/25 | 09/25 | | |
| BARATEAU, Lucie |
DARIDOR-ALZ, NCT05924425: Daridorexant to Treat Insomnia in Patients With Mild Cognitive Impairment and Mild to Moderate Alzheimer Disease |
|
|
| Recruiting | 4 | 62 | Europe | Daridorexant 50 mg, Placebo, Polysomnography, Neuropsychological assessment, Questionnaires on sleep and behavioural problems, Actimetrics, 24-hour Ambulatory Blood Pressure Monitoring (ABPM, Biomarker assay | University Hospital, Montpellier, Idorsia Pharmaceuticals Ltd. | Alzheimer Disease, Insomnia Disorder, Sleep | 05/26 | 03/27 | | |
| Garnier, Sarah |
| No trials found |
| AHMED, Engi |
| No trials found |
| MARTINEZ-TARQUINI, Gaëlle |
| No trials found |
| Compan |
| No trials found |
| Dap |
| No trials found |
| TIKVESA, Dino |
| No trials found |
| PASTOR, Maxime |
| No trials found |
